18 January 2022
A Russian start-up called Troitsk Engineering Center (part of TechnoSpark Group) has developed a special device, the Indicator-BIO, to diagnose viral infections.
Their partners in the project, biologists and physicians from the Federal Medical-Biological Agency (FMBA), have, in their turn, come up with advanced chips and reagents to go with the device, which are said to take within 15 minutes to pinpoint in biological fluids an array of dangerous viruses, including the COVID-19.
The Indicator-BIO’s key advantage is believed to be its compatibility with any reagents available in the market today. In addition, the device requires no specially equipped lab.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024